title: The association between circulating total folate and folate vitamers with overall survival after postmenopausal breast cancer diagnosis.
abstract: We studied the relationship between plasma total folate and folate vitamer concentrations [5-methyltetrahydrofolic acid, pteroylglutamic acid (folic acid) and tetrahydrofolic acid] with overall survival after breast cancer diagnosis. A secondary aim was to assess the relationship between folic acid supplement use with circulating total folate and folate vitamer concentrations. Participants were postmenopausal women diagnosed with breast cancer (n = 498) with an average follow-up of 6.7 yr. Plasma total folate and folate vitamers were measured by isotope-dilution LC-MS/MS in samples collected at or postdiagnosis. Cox proportional multivariate hazards models (controlled for stage, age at diagnosis, body mass index, parity, hormone replacement therapy use, treatment, alcohol use, folic acid use, and energy intake), were used to assess overall survival after breast cancer diagnosis. We found that the relative risk of dying for women with plasma total folate concentrations in the highest quartile was 59% lower (hazard ratio: 0.41, 95% confidence interval: 0.19-0.90) compared with the lowest quartile. Data on supplement use showed that women taking folic acid supplements had significantly higher circulating total folate and folate vitamer concentrations (P < 0.0001), suggesting that increased folate consumption through diet and/or supplementation may improve prognosis after breast cancer diagnosis.
authors: a Department of Health Science , California State University, Fullerton , Fullerton , California , USA.
authors: Archana Jaiswal
authors: AJ
authors: McEligot
authors: Argyrios
authors: A
authors: Ziogas
authors: Christine M
authors: CM
authors: Pfeiffer
authors: Zia
authors: Z
authors: Fazili
authors: Hoda
authors: H
authors: Anton-Culver
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000097:blood* / Q000401:mortality; D019587:Dietary Supplements; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause; D016016:Proportional Hazards Models
chemical_list: D005492:Folic Acid
references: J Genet Genomics. 2009 Apr;36(4):203-14
references: 19376481
references: Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):849-53
references: 10952104
references: Cancer. 1999 Sep 1;86(5):826-35
references: 10463982
references: Nutr Cancer. 2002;44(2):139-44
references: 12734059
references: Am J Clin Nutr. 2008 Sep;88(3):763-8
references: 18779294
references: Eur J Cancer. 2000 Jun;36(10):1200-8
references: 10882857
references: JAMA. 2008 Nov 5;300(17):2012-21
references: 18984888
references: Proc Nutr Soc. 2004 Nov;63(4):529-36
references: 15831124
references: Ann Epidemiol. 2006 Mar;16(3):206-12
references: 16343942
references: Br J Nutr. 2011 Sep;106(6):936-43
references: 21736840
references: Am J Clin Nutr. 2007 Dec;86(6):1773-9
references: 18065598
references: Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):189-93
references: 16492904
references: Am J Clin Nutr. 2010 Dec;92(6):1416-22
references: 20844072
references: Am J Respir Crit Care Med. 2008 Mar 1;177(5):524-30
references: 17989343
references: Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):161-4
references: 12582027
references: Eur J Cancer Prev. 2015 Mar;24(2):113-21
references: 24787380
references: Nutr Cancer. 2006;55(2):132-40
references: 17044767
references: Eur J Cancer. 2011 Aug;47(12):1808-16
references: 21411310
references: Int J Cancer. 2005 Feb 20;113(5):825-8
references: 15499620
references: Am J Clin Nutr. 2007 Sep;86(3):718-27
references: 17823438
references: Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1409-12
references: 16835345
references: Am J Clin Nutr. 2009 Feb;89(2):624-33
references: 19116331
references: J Nutr. 2002 Aug;132(8 Suppl):2413S-2418S
references: 12163703
references: Clin Chem. 2004 Feb;50(2):423-32
references: 14670827
references: Am J Clin Nutr. 2006 Apr;83(4):895-904
references: 16600944
references: Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1439-47
references: 19423522
references: Am J Epidemiol. 1986 Sep;124(3):453-69
references: 3740045
references: Clin Chem. 2004 Dec;50(12):2378-81
references: 15459090
references: Top Health Rec Manage. 1990 Dec;11(2):59-73
references: 10108499
references: Am J Epidemiol. 2006 Jun 1;163(11):989-96
references: 16554345
references: Breast Cancer Res Treat. 2012 Feb;132(1):243-50
references: 22037788
references: Cancer Res. 1988 Nov 15;48(22):6580-3
references: 2846154
references: Arch Intern Med. 2010 Oct 11;170(18):1622-31
references: 20937919
references: JAMA. 2009 Nov 18;302(19):2119-26
references: 19920236
references: Int J Cancer. 2006 Feb 15;118(4):970-8
references: 16152626
references: Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):103-11
references: 10667470
references: Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2416-24
references: 18006931
references: JAMA. 2007 Jun 6;297(21):2351-9
references: 17551129
references: J Nutr. 2000 Feb;130(2):129-32
references: 10720158
references: Clin Chem. 2009 Jun;55(6):1147-54
references: 19359539
references: Metabolism. 2011 May;60(5):673-80
references: 20727555
references: J Natl Cancer Inst. 2007 Jan 3;99(1):64-76
references: 17202114